NWM
NVCR icon

Nauset Wealth Management’s NovoCure NVCR Stock Holding History

Nauset Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$50K Buy
+600
New +$44.2K 0.04% 123

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nauset Wealth Management's NVCR Position: Q1 2022 in Review

Nauset Wealth Management opened a new position in NovoCure (NVCR) in Q1 2022: 600 shares worth $50K. The stake represents 0.04% of the portfolio and ranks #123 among its holdings.

309 funds tracked by Wall St. Rank hold NVCR as of Q1 2022.

  • Nauset Wealth Management held 600 shares of NovoCure worth $50K as of Q1 2022.
  • NovoCure was a new Nauset Wealth Management position in Q1 2022.
  • NovoCure made up 0.04% of Nauset Wealth Management's portfolio in Q1 2022, its #123 holding.
  • 309 funds tracked by Wall St. Rank held NovoCure as of Q1 2022.

Based on Nauset Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.